InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,554.00
(
-2.26%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.00%
)
Bitcoin
64,745.71
(
1.44%
)
Post# of 672
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Tekterra

Send PM Follow Ignore
Followers 13
Posts 1812
Boards Moderated 0
Alias Born 03/29/2016

Tekterra

Re: None

Thursday, 02/09/2017 12:08:19 PM

Thursday, February 09, 2017 12:08:19 PM

Post# of 672
So the understanding was that they didn't get the labeling because of other company with exclusive rights that won't expire until 2018. However, ARYMO showed strong evident of abuse deterrent and will probably get the labeling next year? So it's just up to their sales people to tell doctors and make a sales.

This doesn't sound so bad at all. I wouldn't be surprised to see a jump in quarter 2 earnings.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up